Developing the next generation of oncology therapies for patients.

Avenzo Therapeutics | 6,909 followers on LinkedIn. Developing the next generation of oncology therapies for patients | Developing the next generation of oncology therapies for patients.

Dec 11, 2025 · Explore Avenzo Therapeutics' in-depth company profile, including funding details, key investors, leadership, and competitors.

Sep 25, 2025 · Avenzo Therapeutics Inc. Headquarters: San Diego, CA, United States Website: https://avenzotx.com/ Year Founded: 2022

Nov 17, 2025 · Explore Avenzo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 54 news, Disease Domain:Neoplasms, Endocrinology ...

Aug 21, 2023 · Prior to Avenzo, Ms. Yeganegi served as Senior Vice President, Global Program Team Lead, Head of Medical Affairs and Site Head for Turning Point Therapeutics, where she …

Dec 11, 2024 · Avenzo Therapeutics Granted Fast Track Designation for AVZO-103, a Potential Best-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate, for the Treatment of …

Contact Information For more information about Avenzo Therapeutics’ ongoing clinical trials, please visit the Clinical Trials section of our website. If you have additional questions about our …

The Phase 1/2 first-in-human, open-label clinical study is designed to assess the safety, tolerability, and preliminary clinical activity of AVZO-023 as a single agent and in combination …

Nov 24, 2025 · Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the U.S. Food and Drug …